OBJECTIVES: Due to increasing clinical experience with transcatheter aortic valve implantation (TAVI) procedures, sophisticated imaging and advanced device technology, TAVI complication rates are low; however, patients requiring conversion to surgery are confronted with an increased mortality risk. In this retrospective study, we evaluated the predictors for conversion and the outcomes of these patients.
INTRODUCTION
During the last decade, transcatheter aortic valve implantation (TAVI) has become the preferred treatment for high-risk patients and is increasingly used in elderly, intermediate-risk patients with aortic stenosis. The European guidelines recommend that TAVI should be performed only in hospitals with departments of cardiology and cardiac surgery on-site, and in many countries, reimbursement is linked to the presence of a heart team [1] . In the USA, the Centers for Medicare and Medicaid Services only cover TAVI if 2 cardiac surgeons have independently examined the patient, and an interventional cardiologist and cardiac surgeon are required to participate jointly in the intraoperative technical aspects of TAVI. Similarly, the Federal Joint Committee (Gemeinsamer Bundesausschuss) in charge of quality control of healthcare in Germany determined that indication and performance of TAVI should be carried out by a dedicated heart team consisting of institutionalized cardiologists, cardiac surgeons and anaesthetists.
These requirements are comprehensible, considering that TAVI, in its early years, represented a new treatment option and was associated with increased morbidity and mortality rates. However, due to improved devices, better patient selection and greater experience, TAVI has become a routine procedure. It is now considered safe, with a low rate of conversion to sternotomy and very few complications requiring extracorporeal circulatory support [2] . The main benefit of a fully trained interdisciplinary team (cardiology and cardiac surgery) being actively present during TAVI procedures is the ability to immediately treat all possible complications. In spite of improved outcomes, however, little is known about the current conversion rates and the further course of TAVI patients who required conversion due to complications. Therefore, we analysed the incidence and the reasons for conversions, the therapy applied and short-and mid-term outcomes.
METHODS
All patients who underwent TAVI between January 2011 and December 2016 at the Kerckhoff Heart Center were included in the current analysis. Data from our institutional database were used to identify patients who required conversion (up to 6 h after the initial TAVI procedure) due to complications during a TAVI procedure. TAVI was performed as previously described using balloon-expandable or non-balloon-expandable TAVI devices with either a transapical or a transfemoral approach [3] [4] [5] . At our institution, all patients considered eligible for TAVI are discussed in a meeting of the heart team consisting of anaesthetists, cardiologists and cardiac surgeons who meet at least 3 times a week. In almost all cases, the same team that decided on TAVI indication, access route and valve type performs the TAVI procedure. Since the beginning of the TAVI programme at our institution, all procedures are performed by a cardiac surgeon and a cardiologist who are both familiar of performing transapical as well as transfemoral TAVI.
Reasons for conversion, follow-up therapy after sternotomy and postoperative outcomes were analysed. The study was performed in accordance with the Declaration of Helsinki and was approved by the institutional review board at our centre.
Statistical analysis
Unadjusted bivariate analyses comparing characteristics of patients converted to sternotomy with those whose procedures were not converted were conducted using Fisher's exact tests for categorical variables and Wilcoxon rank-sum tests for continuous variables. For the patients who were converted, an identical bivariate analysis was conducted comparing those who survived >30 days post-procedure with those who did not. Because of the limited number of conversions, multivariate analysis with more than 4 degrees of freedom (i.e. confounding factors) would be inappropriate [6] . However, we tested the effects of 3 risk factors (balloon-expandable valve, status post-cardiac surgery and Agatson score) which we expected to be most strongly associated with conversion using a logistic regression model adjusted for EuroSCORE II. Odds ratios and Wald 95% confidence intervals were reported. These analyses were conducted using SAS 9.4 (SAS Inc., Cary, NC, USA).
Finally, we did an analysis to determine the statistical power to detect a range of effect sizes for each of the 3 variables in the model. We also reported the needed sample size to achieve 80% power for each effect size. For the power analysis, we used 2-tailed tests with a = 0.05 and assumed a moderate correlation of 0.6 between the variables in the model. The power analysis was conducted using G*Power version 3.1.9.2, Universität Kiel, Germany.
RESULTS
During the observation period, 1775 patients underwent TAVI. Of these, 32 (2.1%) patients required immediate conversion to sternotomy, with a trend towards a decreasing conversion rate over time (Fig. 1) . Baseline characteristics between the 2 groups were similar ( Table 2) .
The complications that led to conversion varied. One patient required conversion due to residual aortic regurgitation resulting in haemodynamic instability; in another patient, the TAVI valve interacted with the previously implanted mechanical mitral valve prosthesis and caused severe mitral regurgitation; the TAVI balloon ruptured in another patient without expanding the prosthesis, causing haemodynamic instability. Annular rupture occurred in 5 (16%) patients; in 9 (28%) patients, the TAVI valve embolized either into the ventricle (n = 3) or into the ascending aorta (n = 6), and 15 (47%) patients had pericardial tamponade most commonly due to ventricular perforation caused by a wire.
Cardiopulmonary bypass was used in most cases (30 of 32) to stabilize the patients, and 21 (65%) patients underwent aortic valve replacement after conversion to sternotomy. Thirty-day mortality was 44% (14 of 32 patients). Table 3 summarizes the characteristics of the patients who survived and those who did not survive 30 days after conversion during TAVI. Patients who survived 30 days after conversion showed higher preoperative ejection fraction (60.3 ± 13.6% vs 50.9 ± 14.9%; P = 0.02), shorter duration of surgery (193 ± 68 min vs 259 ± 93 min; P = 0.05) and shorter perfusion time (89 ± 51 min vs 144 ± 70 min; P = 0.03).
Of the remaining 18 patients who survived 30 days, 13 (72.3%) were still alive at the 1-year follow-up.
DISCUSSION
In this large, single-centre study, while analysing reasons and possible predictors of conversion to surgery during TAVI, we are able to report promising results regarding the immediate outcome of these patients who experienced serious complications during the procedure. Furthermore, by means of a case-by-case analysis, we identify specific reasons for conversion. One major finding is that the clinical history and demographics of patients requiring conversion are very similar to those not requiring conversion, indicating that the main reasons for conversion to sternotomy are most likely unsuitable anatomy, prosthesis mismatch and errors during TAVI implantation. Driven by a higher rate of valve embolization, the use of a self-expandable valve showed to be a significant predictor for conversion to sternotomy. However, the main reason for conversion was pericardial tamponade, a complication that is most likely not impacted by the valve type. Thus, there were no reliable preoperative predictors of the need for conversion identified, and experienced cooperation of cardiologists and cardiac surgeons within the heart team is recommended for optimal patient safety. Along these lines, it should be noted that although the immediate mortality rate is high in patients requiring conversion, over half of the patients survived the first 30 days. In these cases, the absence of on-site cardiac surgery could have resulted in a fatal outcome.
A comparison of different studies investigating conversion rates and the outcome of these procedures is complicated due to heterogeneous definitions. One of the main issues is whether a sternotomy alone during the TAVI procedure itself meets the definition of conversion or whether surgery during the first postprocedural hours (e.g. within 24 h) is included in the analysis. In our experience, whenever surgery is needed during the 1st hour after surgery, it is often related to initially covered ventricular perforations that worsen, result in pericardial tamponade and require prompt drainage and further cardiac repair. As our analysis corresponded to TAVI, we included patients needing cardiac surgery up to 6 h after the initial TAVI procedure.
Another confounding aspect in evaluating such studies is whether only patients who underwent sternotomy and extracorporeal circulation should be classified as undergoing conversion. Applying this definition to an analysis excludes patients undergoing immediate cardiac surgery without the need for extracorporeal circulation. In our opinion, this holds 2 problems: first, the number of patients deemed as requiring immediate cardiac surgery is underestimated and second, the outcome of patients undergoing surgery is artificially poor. There are patients with pericardial tamponade, for example who can be safely treated by sternotomy with pericardial drainage and surgical closure of the puncture site using myocardial sutures on the beating heart without cardiopulmonary bypass; we regard these patients as having undergone conversion, despite the absence of extracorporeal circulation.
Bearing all of these difficulties with variable definitions in mind, we obtained results that were similar to those of several published studies. A meta-analysis of 46 studies including 9251 patients reported emergent cardiac surgery in 1-7.7% of cases [7] . We furthermore showed that maybe due to gained experience, improved patient selection and TAVI devices, the rate of conversion declined over time. Interestingly, this decline was not driven by a reduction of a single complication leading to cardiac surgery. The 30-day mortality was 67% for these patients but varied widely between the different studies. One of the studies in the analysis reported a low 30-day mortality of 35% in 21 of 411 patients requiring conversion during TAVI [8] .
Guenther et al. [9] investigated the outcome of 8 patients who required immediate conversion and surgical aortic valve replacement during TAVI and reported a 30-day mortality of 37%; however, they did not mention patients requiring conversion without surgical aortic valve replacement. Of note, the surgical backup setting in these institutions was similar to the one in this study.
Risk factors for conversion
In our study, baseline characteristics were shown to be similar between those with and without conversion. The only differences were significantly more female patients, less frequent prior cardiac surgery, less frequent diabetes and less use of balloonexpandable devices in the conversion group. Recently, Chandrasekhar et al. [10] showed in an analysis of the STS/ American College of Cardiology (ACC) Transcatheter Valve Therapy (TVT) Registry that both conversion to open surgery (1.7% vs 1.0%) and the use of emergent cardiopulmonary bypass (2.9% vs 2.2%) occurred more frequently in female patients. However, the reasons for this gender difference remain unclear at present. It may be that female patients are at a slightly higher risk of ventricular perforation and thus pericardial effusion due to smaller left ventricles. Prior cardiac surgery might potentially prevent conversion, as it causes pericardial adhesions and thus might lower the risk of pericardial tamponade, which was the leading cause of conversion to sternotomy in our cohort. The higher rate of self-expandable valve usage in the conversion group might be due to the fact that the implantation of these devices requires more wire manipulation, increasing the risk of ventricular perforation.
The severity and distribution of aortic valve calcification have been identified as important determinants of procedural outcome (e.g. paravalvular leakage) [11] [12] [13] [14] [15] . Other studies showed that calcification and left ventricular outflow tract calcification are predictors of annular injury and rupture [16, 17] . Further risk factors for annular rupture are aggressive annular oversizing (often unavoidable in small annular diameters) and post-dilatation [16] . However, in this study, none of these parameters were shown to be different between the 2 groups. This is probably due to annular rupture being a rare event or the proper matching of patient and prosthesis, reducing the risk of annular rupture.
Risk factors that impact outcome after conversion
In this study, preoperative ejection fraction was the only baseline characteristic that was different between the survivors and the non-survivors of conversion during TAVI. Walther et al. [2] investigated the outcome of 15 964 patients from the German Aortic Valve Registry (GARY) and showed that reduced left ventricular function is one of the predictors of 30-day mortality. Duncan et al. [18] confirmed that the impact of ejection fraction on survival is sustained at the 3-year follow-up. The inferior outcome of patients with low ejection fraction can be additionally explained by their poor tolerance to the low blood pressure that is present during most events requiring conversion.
Impact of a heart team
As discussed, baseline characteristics of TAVI patients do not allow us to predict the risk of conversion, and thus the occurrence of conversion, which fortunately is a rare event, remains unpredictable. Our study confirms prior reports of acceptable 30-day and 1-year survival among patients undergoing sternotomy during TAVI. This is most likely caused by stabilization and emergent cardiac surgery of the patient in a timely manner by a well-trained and designated TAVI team as well as proper infrastructure. In addition, the presence of a hybrid operating room is an infrastructural component that might be of particular importance in cases of life-threatening complications such as annular rupture or ventricular perforation requiring immediate conversion. Thus, Hein et al. [19] analysed 24 of 1975 patients in the German TAVI registry and showed a higher mortality after conversion in patients treated in a catheterization laboratory compared with a hybrid operating room. These findings, similar to those of other reports, support the concept that TAVI should be performed in a hybrid operating room by a team of cardiologists and cardiac surgeons [20, 21] .
Limitations
Our study has a number of limitations. First, although we included almost 1800 patients in this study, larger patient cohorts are needed to confirm our findings. This is especially important for further characterization of risk factors associated with specific reasons for conversion. The performed power analysis (Table 4) shows that due to the needed large sample size, these questions can only be answered by registry-based studies. Second, we report only 30-day and 1-year results, as we cannot provide data from a longer follow-up period. Third, a principal limitation of this analysis is the retrospective analysis of the data. However, data were collected prospectively. An accurate statistical analysis of exact mechanisms that led to valve embolization or pericardial tamponade (e.g. type of valves or wires) was not possible due to the limited number of events and the retrospective nature of the study.
CONCLUSION
Although patients requiring conversion to surgery during TAVI are at very high risk of serious morbidity and mortality, our findings underline that by immediate conversion many of them can be saved. The current guidelines recommend an interdisciplinary cooperation of cardiologists and cardiac surgeons during TAVI procedures. This would not be necessary if an uneventful TAVI procedure could be guaranteed. However, as complications requiring conversion are unpredictable, the presence of a heart team is essential to provide optimal care for every TAVI patient. 
